Replimune (REPL) Assets (2018 - 2025)
Replimune has reported Assets over the past 8 years, most recently at $333.6 million for Q4 2025.
- Quarterly results put Assets at $333.6 million for Q4 2025, down 44.74% from a year ago — trailing twelve months through Dec 2025 was $333.6 million (down 44.74% YoY), and the annual figure for FY2025 was $551.3 million, up 13.04%.
- Assets reached $333.6 million in Q4 2025 per REPL's latest filing, down from $389.4 million in the prior quarter.
- Across five years, Assets topped out at $678.6 million in Q4 2022 and bottomed at $333.6 million in Q4 2025.
- Median Assets over the past 5 years was $513.6 million (2021), compared with a mean of $515.3 million.
- The largest annual shift saw Assets skyrocketed 132.0% in 2021 before it tumbled 44.74% in 2025.
- Over 5 years, Assets stood at $485.3 million in 2021, then surged by 39.83% to $678.6 million in 2022, then fell by 21.46% to $532.9 million in 2023, then rose by 13.27% to $603.6 million in 2024, then plummeted by 44.74% to $333.6 million in 2025.
- Business Quant data shows Assets for REPL at $333.6 million in Q4 2025, $389.4 million in Q3 2025, and $469.5 million in Q2 2025.